Department of Anesthesia and Critical Care Medicine, Azienda Ospedaliera "SS Antonio e Biagio e C. Arrigo", Alessandria, Italy.
Department of Research and Innovation-Research Training Innovation Infrastructure, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
Rev Recent Clin Trials. 2023;18(1):12-18. doi: 10.2174/1574887117666220810121048.
Cerebral vasospasm is one of the frequent complications that can occur following subarachnoid hemorrhage (SAH). With new protocols in the management of SAH, the combined risk of death and long-term disability have been reduced by about 10% compared with the past.
This work aims to report the latest updates on the vasospasm developing after the SAH in patients in the ICU department. In this short review, we reviewed the latest scientific findings on the mechanisms of vasospasm, and in addition, we considered it necessary to review the literature to report the tools for early diagnosis of vasospasm and the best treatment strategies to prevent the negative outcome in patients admitted to ICU.
The aim of this narrative review is to report the main characteristics of vasospasm, new diagnostic methods, and, especially, more effective treatment of vasospasm.
The peer-reviewed articles analyzed were selected from PubMed, Google scholar, Embase, and Scopus databases published in the previous 20 years using the keywords "vasospasm", "vasospasm diagnosis", "vasospasm and SAH", "vasospasm treatment", and nontraumatic brain injury. Among the 78 papers identified, 43 articles were selected; after the title - abstract examination and removing the duplicates, only 31 articles were examined.
Vasospasm can be classified according to clinical (asymptomatic vs. symptomatic) and diagnostic (angiographic vs. ultrasound) methods. Various procedures such as TCD and CT perfusion are used for early diagnosis and close monitoring of this condition. The treatment of vasospasm consists of both prevention (nimodipine, statitis, and magnesium sulphate) and active treatment (mainly endovascular).
As the review shows, vasospasm is a complication of SAH, a complication that is difficult to recognize early and treat with the best outcome. However, with the equipment we have, it has been possible to improve the outcome, even if it is still not ideal, in patients who develop vasospasm. Several studies are in the final stages to improve the outcome of this unfortunately frequent condition.
蛛网膜下腔出血(SAH)后常发生脑血管痉挛。随着 SAH 治疗新方案的出现,与过去相比,死亡和长期残疾的综合风险降低了约 10%。
本工作旨在报道 ICU 部门患者发生的 SAH 后血管痉挛的最新进展。在这篇简短的综述中,我们回顾了血管痉挛发生机制的最新科学发现,此外,我们认为有必要回顾文献,报告血管痉挛的早期诊断工具和预防 ICU 患者不良结局的最佳治疗策略。
本叙述性综述的目的是报告血管痉挛的主要特征、新的诊断方法,特别是更有效的血管痉挛治疗方法。
从 PubMed、Google Scholar、Embase 和 Scopus 数据库中分析了同行评议的文章,使用关键词“血管痉挛”、“血管痉挛诊断”、“血管痉挛和 SAH”、“血管痉挛治疗”和“非创伤性脑损伤”,检索了过去 20 年发表的文章。在确定的 78 篇论文中,选择了 43 篇文章;经过标题-摘要检查并去除重复后,仅检查了 31 篇文章。
血管痉挛可根据临床(无症状与有症状)和诊断(血管造影与超声)方法进行分类。TCD 和 CT 灌注等各种程序用于早期诊断和密切监测这种情况。血管痉挛的治疗包括预防(尼莫地平、他汀类药物和硫酸镁)和积极治疗(主要是血管内)。
正如综述所示,血管痉挛是 SAH 的一种并发症,这种并发症早期难以识别,治疗效果也不理想。然而,通过我们现有的设备,已经有可能改善发生血管痉挛的患者的预后,即使预后仍不理想。有几项研究已进入最后阶段,以改善这种不幸的常见情况的预后。